M

Seres Therapeutics
D

MCRB

7.99000
USD
-0.01
(-0.13%)
مغلق
حجم التداول
810
الربح لكل سهم
-9
العائد الربحي
-
P/E
-2
حجم السوق
77,374,633
أصول ذات صلة المقالات
المزيد

العنوان: Seres Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.